|
JFL Life Sciences Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
41.24 Cr.
|
P/BV
|
1.16
|
Book Value (Rs.)
|
10.78
|
|
52 Week High/Low (Rs.)
|
37/12
|
FV/ML
|
10/6000
|
P/E(X)
|
9.92
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
1.26
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 70.30 | 24.84 |
| Total Income From Operations | 70.30 | 24.84 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 61.92 | 18.41 |
| Increase/Decrease in Stocks | -0.91 | 0.65 |
| Employees Cost | 1.27 | 1.63 |
| Depreciation | 0.64 | 0.34 |
| Other Expenses | 1.22 | 1.35 |
| Total Expenses | 64.14 | 22.37 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 6.17 | 2.47 |
| Other Income | 0.01 | 0.50 |
| P/L Before Interest, Excpt. Items & Tax | 6.18 | 2.97 |
| Interest | 0.74 | 0.55 |
| P/L Before Exceptional Items & Tax | 5.45 | 2.42 |
| P/L Before Tax | 5.45 | 2.42 |
| Tax | 1.37 | 0.31 |
| P/L After Tax from Ordinary Activities | 4.07 | 2.10 |
| Net Profit/Loss For the Period | 4.07 | 2.10 |
| | | |
| Equity Share Capital | 33.00 | 11.00 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 1.23 | 0.64 |
| Diluted EPS (Rs.) | 1.23 | 0.64 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 1.23 | 0.64 |
| Diluted EPS (Rs.) | 1.23 | 0.64 |
| | | |
| PBITOE Margin (%) | 8.77 | 9.95 |
| PBTE Margin (%) | 7.74 | 9.72 |
| PBT Margin (%) | 7.74 | 9.72 |
| PAT Margin (%) | 5.79 | 8.45 |
